These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3197745)

  • 21. Binding of pirprofen with serum albumin obtained from uremic patients.
    Mohammed MS; Abdel Hady SS; Mahdy MA; Mohammed AI
    Pharmazie; 1995 Mar; 50(3):226-7. PubMed ID: 7732061
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
    Jung D; Mroszczak E; Bynum L
    Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the (+)- and (-)-enantiomers of pirprofen in human plasma by high-performance liquid chromatography.
    Sioufi A; Colussi D; Marfil F; Dubois JP
    J Chromatogr; 1987 Feb; 414(1):131-7. PubMed ID: 3494738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of aspirin on 14C-pirprofen disposition in rats.
    Thompson TA; Borman CH; Goodblatt RS; Roth WJ
    J Pharm Sci; 1979 Aug; 68(8):996-8. PubMed ID: 480180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques.
    Otagiri M; Masuda K; Imai T; Imamura Y; Yamasaki M
    Biochem Pharmacol; 1989 Jan; 38(1):1-7. PubMed ID: 2910295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]- pyridine-7-acetate (Y-23023), a new prodrug type of anti-inflammatory agent, and indomethacin after oral administrations in rats.
    Yamada I; Nagamatsu Y; Imayoshi T; Shibata M; Tsuji A
    J Pharm Pharmacol; 1994 Jul; 46(7):614-6. PubMed ID: 7996395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased oral bioavailability of loxoprofen at second administration in human subjects.
    Kim IW; Choo KS; Han TG; Kim KS; Chung SJ; Lee MH; Shim CK
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):10-4. PubMed ID: 10667831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the dermatopharmacokinetic profile of two loxoprofen patches for bioequivalence confirmation.
    Chen X; Matsuzawa T; Hitsu E; Zhong W; Qian Z; Jiang J; Hu P
    Int J Clin Pharmacol Ther; 2015 May; 53(5):412-3. PubMed ID: 25828640
    [No Abstract]   [Full Text] [Related]  

  • 30. Altered metabolism of orally administered loxoprofen in human subjects after an oral administration of loxoprofen for three consecutive days followed by a seven-day washout.
    Kim IW; Chung SJ; Shim CK
    J Pharm Sci; 2002 Apr; 91(4):973-9. PubMed ID: 11948535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rengasil (pirprofen) in the treatment of inflammatory eye diseases].
    Maĭchuk IuF; Kazachenko MA; Diadina UV
    Oftalmol Zh; 1990; (5):290-2. PubMed ID: 2089328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis due to pirprofen; 3 cases, 1 fatality].
    Fouin-Fortunet H; Lerebours E; Bernet J; Hemet J; Colin R
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):23-5. PubMed ID: 2938537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of loxoprofen and its active metabolite after dermal application of loxoprofen gel to rats.
    Sawamura R; Kazui M; Kurihara A; Izumi T
    Pharmazie; 2015 Feb; 70(2):74-80. PubMed ID: 25997245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of pirprofen].
    Hirtz J; Bartlett MF
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):164-9. PubMed ID: 3872824
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic studies of indoprofen in healthy volunteers and in patients.
    Caruso I; Corvi G; Fuccella LM; Moro E; Sacchetti G; Tamassia V; Tosolini GP
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):411-6. PubMed ID: 303237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis.
    Christophidis N; Rotstein A; Louis WJ
    Clin Exp Pharmacol Physiol; 1986 Jul; 13(7):555-61. PubMed ID: 3791708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iontophoretic administration of pirprofen or lysine soluble aspirin in the treatment of rheumatic diseases.
    Garagiola U; Dacatra U; Braconaro F; Porretti E; Pisetti A; Azzolini V
    Clin Ther; 1988; 10(5):553-8. PubMed ID: 2856598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of single and multiple doses of tiaprofenic acid in elderly patients with arthritis.
    Hosie J; Hosie GA
    Eur J Clin Pharmacol; 1987; 32(1):93-5. PubMed ID: 3582474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states.
    Taylor IW; Taylor T; James I; Doyle G; Dorf G; Darragh A; Chasseaud LF
    Eur J Clin Pharmacol; 1991; 40(1):101-6. PubMed ID: 2060536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioavailability of nimesulide in goats.
    Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
    J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.